Salud Mental

Joint statement on dual disorders: Addiction and other mental disorders


Néstor Szerman
José Martínez-Raga
Rubén Baler
Carlos Roncero
Pablo Vega,
Ignacio Basurte
Lara Grau-López
Marta Torrens,
Miguel Casas
Celia Franco
Giampaolo Spinnato
Icro Maremmani
Angelo G.I. Maremmani
Jean-Pierre Daulouède
Arkaitz Aguerretxe-Colina
Karl Mann
Rodrigo Marín-Navarrete
María Elena Medina-Mora
Pedro Ruiz


The World Association on Dual Disorders (WADD), the World Psychiatric Association (WPA) (Section on Dual Disorders), and the Sociedad Española de Patología Dual (SEPD) have joined forces to clarify that:

Addiction is a mental disorder, not a voluntary, self-indulgent act.


Download data is not yet available.


American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: American Psychiatric Association. doi: 10.1176/appi.books.9780890425596.744053

Arias, F., Szerman, N., Vega, P., Mesias, B., Basurte, I., Morant, C., … & Babín, F. (2013). Madrid study on the prevalence and characteristics of outpatients with dual pathology in community mental health and substance misuse services. Adicciones, 25(2), 118-27. doi: 10.1080/17523281.2012.748674

Greenfield, S. F., & Weiss, R. D. (2015). Harvard Review of Psychiatry: Introduction. Harvard Review of Psychiatry, 23(2), 61-62. doi: 10.1097/HRP.0000000000000074

Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N., Winters, K. C., & Shaffer, H. J. (2008). DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychological Medicine, 38(9), 1351-1360. doi: 10.1017/S0033291708002900

Lev-Ran, S., Imtiaz, S., Rehm, J., & Le Foll, B. (2013). Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). American Journal on Addictions, 22(2), 93-98. doi:10.1111/j.1521-0391.2013.00304.x

Leyton, M., & Vezina, P. (2014). Dopamine ups and downs in vulnerability to addictions: A neurodevelopmental model. Trends in Pharmacological Sciences. doi: 10.1016/

Mann, K., Roos, C., Hoffmann, S., Nakovics, H., Leméganer, T., Heinz, A., & Wictiewitz, K. (2017). Precision medicine in alcohol dependence: A controlled trial testing pharmacotherapy response among reward an relief dinking phenotype. Neuropsychopharmacology. Retrieved from:

Minkoff, K. (2001). Best Practices: Developing Standards of Care for Individuals With Co-occurring Psychiatric and Substance Use Disorders. Psychiatric Services, 52(5), 597-599. doi: 10.1176/

National Institute on Drug Abuse. (2007). Addiction and co-occurring mental disorders.

Roncero, C., Barral, C., Rodríguez-Cintas, L., Pérez-Pazos, J., Martinez-Luna, N., Casas, M., … & Grau-López, L. (2016). Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: The PROTEUS study. Psychiatry Research, 243, 174-181. doi: 10.1016/j.psychres.2016.06.024

Szerman, N., & Martinez-Raga, J. (2015). Editorial. Advances in Dual Diagnosis, 8(2). doi: 10.1108/ADD-03-2015-0004

Szerman, N., Martinez-raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., … & Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12(1). doi: 10.1097/ADT.0b013e31826e7b6a

Van Os, J., Delespaul, P., Wigman, J., Myin-Germeys, I., & Wichers, M. (2013). Beyond DSM and ICD: Introducing “precision diagnosis” for psychiatry using momentary assessment technology. World Psychiatry, 12(2), 113-117. doi: 10.1002/wps.20046

Volkow, N. D. (2001). Drug abuse and mental illness: Progress in understanding comorbidity. American Journal of Psychiatry, 158(8), 1181-1183. doi: 10.1176/appi.ajp.158.8.1181

Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. The New England Journal of Medicine, 374(4), 363-371. doi: 10.1056/NEJMra1511480